CVE-2022-2197

Exemys RME1

Description

By using a specific credential string, an attacker with network access to the device’s web interface could circumvent the authentication scheme and perform administrative operations.

Remediation

Solution:

  • Exemys no longer sells or maintains RME1 and considers it to be an end-of-life product. Exemys recommends updating to a new supported product in RME2. For more information on upgrading, contact Exemys support.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.09%
Third-Party Advisory cisa.gov
Affected: Exemys RME1-AI firmware
Published at:
Updated at:

References

Link Tags
https://www.cisa.gov/uscert/ics/advisories/icsa-22-181-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2022-2197?
CVE-2022-2197 has been scored as a critical severity vulnerability.
How to fix CVE-2022-2197?
To fix CVE-2022-2197: Exemys no longer sells or maintains RME1 and considers it to be an end-of-life product. Exemys recommends updating to a new supported product in RME2. For more information on upgrading, contact Exemys support.
Is CVE-2022-2197 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-2197 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-2197?
CVE-2022-2197 affects Exemys RME1-AI firmware.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.